flag flag  

Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis

Description : Background The beneficial effects of interferon beta have only been shown for patients in the relapsing-remitting phase of multiple sclerosis (MS). The role of interferon beta in the treatment of patients who are in the secondary progressive phase of the disease (SP-MS), and for whom no effective dr...
Language(s) : Undetermined
Subject(s) : STATUS SCALE EDSS, IMPAIRMENT
Publisher(s) : LANCET LTD
Contributor(s) :
Source(s) :
Publication Date(s) : 1998-11-07